Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Rybak, J. Fett, Q. Yao, B. Vallée (1987)
Angiogenin mRNA in human tumor and normal cells.Biochemical and biophysical research communications, 146 3
SM Karim (1972)
The prostaglandins
D. Ribatti, A. Vacca, L. Roncali, F. Dammacco (1991)
Angiogenesis under normal and pathological conditions.Haematologica, 76 4
J. Bauer, M. Margolis, C. Schreiner, C. Edgell, J. Azizkhan, E. Lazarowski, R. Juliano (1992)
In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrinsJournal of Cellular Physiology, 153
R. Gibbs, R. Romero, S. Hillier, D. Eschenbach, R. Sweet (1992)
A review of premature birth and subclinical infection.American journal of obstetrics and gynecology, 166 5
M. Wennergren, G. Wennergren, G. Vilbergsson (1988)
Obstetric Characteristics and Neonatal Performance in a Four-Year Small for Gestational Age PopulationObstetrics & Gynecology, 72
L. Díaz-Flores, R. Gutiérrez, H. Varela (1994)
Angiogenesis: an update.Histology and histopathology, 9 4
C. Salafia, C. Vogel, A. Vintzileos, Kimberly Bantham, J. Pezzullo, L. Silberman (1991)
Placental pathologic findings in preterm birth.American journal of obstetrics and gynecology, 165 4 Pt 1
R. Williams, R. Creasy, G. Cunningham, W. Hawes, F. Norris, M. Tashiro (1982)
Fetal Growth and Perinatal Viability in CaliforniaObstetrics & Gynecology, 59
M. Hediger, T. Scholl, J. Schall, L. Miller, R. Fischer (1995)
Fetal Growth and the Etiology of Preterm DeliveryObstetrics & Gynecology, 85
Ghidini (1996)
Elevated midtrimester amniotic fluid tumor necrosis alpha levels: a predictor of preterm delivery [abstract]Am J Obstet Gynecol, 174
S. Weremowicz, E. Fox, C. Morton, B. Vallée (1990)
Localization of the human angiogenin gene to chromosome band 14q11, proximal to the T cell receptor alpha/delta locus.American journal of human genetics, 47 6
L. Furcht (1986)
Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors.Laboratory investigation; a journal of technical methods and pathology, 55 5
I. Brosens, H. Dixon, W. Robertson (1977)
FETAL GROWTH RETARDATION AND THE ARTERIES OF THE PLACENTAL BEDBJOG: An International Journal of Obstetrics & Gynaecology, 84
R. Romero, M. Mazor, H. Muñoz, R. Gómez, M. Galasso, D. Sherer (1994)
The Preterm Labor SyndromeAnnals of the New York Academy of Sciences, 734
B. Zetter (1988)
Angiogenesis. State of the art.Chest, 93 3 Suppl
G. Cockerill, J. Gamble, M. Vadas (1995)
Angiogenesis: models and modulators.International review of cytology, 159
William Ott (1993)
Intrauterine growth retardation and preterm delivery.American journal of obstetrics and gynecology, 168 6 Pt 1
F. Wolf, Ivo Brosens, M. Renaer (1980)
FETAL GROWTH RETARDATION AND THE MATERNAL ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN THE ABSENCE OF SUSTAINED HYPERTENSIONBJOG: An International Journal of Obstetrics & Gynaecology, 87
F. Arias, Laritza Rodriquez, S. Rayne, F. Kraus (1993)
Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes.American journal of obstetrics and gynecology, 168 2
Weremowicz (1990)
Localization of the human angiogenin gene to chromosome band 14q11, proximal to the T cell receptor α/γlocusAm J Hum Genet, 47
OBJECTIVE: Neovascularization is a response of tissue to ischemic damage. Placental ischemia is thought to underlie a significant portion of preterm deliveries. Our objective was to evaluate whether angiogenin, a potent inducer of neovascularization, is increased in midtrimester amniotic fluid of patients destined to be delivered preterm. STUDY DESIGN: We designed a case-control study of singleton gestations undergoing midtrimester amniocentesis for standard genetic indications. Inclusion criteria were (1) pregnancy outcome information available, (2) gestational age at amniocentesis 15 to 20 weeks, (3) no evidence of fetal structural or chromosomal anomalies, and (4) absence of conditions associated with preterm delivery. Amniotic fluid angiogenin levels were measured by immunoassay and normalized by natural log transformation for statistical analysis. RESULTS: Eleven patients with preterm deliveries were matched with 33 controls. Amniotic fluid angiogenin levels were significantly higher in patients with preterm deliveries compared with controls (median 30.1 ng/ml (range 13.6 to 71.0 ng/ml) vs 17.8 ng/ml (7.8 to 43.3 ng/ml), p = 0.002). Demographic data were not significantly different. The association between angiogenin levels and preterm delivery persisted after small-for-gestational-age neonates were excluded ( p = 0.02). Receiver-operator characteristic curve analysis showed that an angiogenin level of 31.0 ng/ml was the optimal cutoff point for prediction of preterm delivery (sensitivity 45.5%, specificity 91.0%, p = 0.03, odds ratio 6.0). CONCLUSIONS: Midtrimester amniotic fluid angiogenin levels are elevated in patients with preterm delivery. This supports the theory that preexisting intrauterine ischemia and inflammation are important risk factors for preterm delivery and may be already present in the early midtrimester. (Am J Obstet Gynecol 1997;176:415-8.)
American Journal of Obstetrics and Gynecology – Wolters Kluwer Health
Published: Feb 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.